MXPA03011153A - Adn enzimas bcl-2. - Google Patents
Adn enzimas bcl-2.Info
- Publication number
- MXPA03011153A MXPA03011153A MXPA03011153A MXPA03011153A MXPA03011153A MX PA03011153 A MXPA03011153 A MX PA03011153A MX PA03011153 A MXPA03011153 A MX PA03011153A MX PA03011153 A MXPA03011153 A MX PA03011153A MX PA03011153 A MXPA03011153 A MX PA03011153A
- Authority
- MX
- Mexico
- Prior art keywords
- bcl
- dnazymes
- catalytic domain
- domain
- nucleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
Abstract
Una prenda desechable incluye una empaquetadura alrededor de una o mas aberturas para las piernas, brazos, cintura o similares sobre un usuario. Por lo menos una parte de la prenda incluye un material elastico de objetivo incluyendo zonas de tension elastica alta y baja y/o de estiramiento alto y bajo en el mismo material integrado durante la formacion del material. El material elastico de objetivo es colocado de manera que por lo menos una zona de alta tension y/o de bajo estiramiento esta alineada con por lo menos una abertura de prenda, y por lo menos una zona de baja tension y/o de alto estiramiento esta alineada hacia adentro de la zona de alta tension y/o de estiramiento, funcionando por tanto como una empaquetadura sin requerir una banda elastica sujetada y fabricada separadamente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR5527A AUPR552701A0 (en) | 2001-06-07 | 2001-06-07 | Bcl-2 dnazymes |
PCT/AU2002/000739 WO2002099090A1 (en) | 2001-06-07 | 2002-06-07 | Bcl-2 dnazymes |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03011153A true MXPA03011153A (es) | 2004-03-26 |
Family
ID=3829501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03011153A MXPA03011153A (es) | 2001-06-07 | 2002-06-07 | Adn enzimas bcl-2. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20050064407A1 (es) |
EP (1) | EP1402007A1 (es) |
JP (1) | JP2004532046A (es) |
KR (1) | KR20040028771A (es) |
AU (1) | AUPR552701A0 (es) |
BR (1) | BR0210189A (es) |
CA (1) | CA2449940A1 (es) |
IL (1) | IL159197A0 (es) |
MX (1) | MXPA03011153A (es) |
WO (1) | WO2002099090A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7482158B2 (en) * | 2004-07-01 | 2009-01-27 | Mathison Brian H | Composite polynucleic acid therapeutics |
CN101940783A (zh) * | 2010-08-03 | 2011-01-12 | 孙仑泉 | 脱氧核酶在制备增强肿瘤化疗敏感性的药物中的应用 |
CN101914538A (zh) * | 2010-08-03 | 2010-12-15 | 孙仑泉 | 一种促进肿瘤细胞凋亡的脱氧核酶 |
CN106047874B (zh) * | 2016-06-02 | 2019-01-18 | 吉林大学 | 一种靶向sall4基因的脱氧核酶分子及在乳腺癌基因治疗中的应用 |
US20210022324A1 (en) * | 2018-03-05 | 2021-01-28 | Dr. Reddy's Institute Of Life Sciences | Embryonic zebrafish models using dnazyme mediated knockdown |
CN112410295B (zh) * | 2020-11-20 | 2023-07-28 | 华东理工大学 | 一种控制细胞间相互作用的细胞表面工程方法及其应用 |
EP4267742A2 (en) | 2020-12-28 | 2023-11-01 | 1E Therapeutics, Ltd. | P21 mrna targeting dnazymes |
AU2021411103A1 (en) * | 2020-12-28 | 2023-07-13 | 1E Therapeutics, Ltd. | P21 mrna target areas for silencing |
GB202107029D0 (en) * | 2021-05-17 | 2021-06-30 | Univ Of Essex Enterprises Limited | DNAzyme design |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001992A (en) * | 1999-01-07 | 1999-12-14 | Isis Pharmaceuticals Inc. | Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
US5539094A (en) * | 1993-11-12 | 1996-07-23 | La Jolla Cancer Research Foundation | DNA encoding Bcl-2-associated proteins |
AUPN896596A0 (en) * | 1996-03-27 | 1996-04-26 | Walter And Eliza Hall Institute Of Medical Research, The | Therapeutic molecules |
US6214986B1 (en) * | 1998-10-07 | 2001-04-10 | Isis Pharmaceuticals, Inc. | Antisense modulation of bcl-x expression |
-
2001
- 2001-06-07 AU AUPR5527A patent/AUPR552701A0/en not_active Abandoned
-
2002
- 2002-06-07 IL IL15919702A patent/IL159197A0/xx unknown
- 2002-06-07 BR BR0210189-0A patent/BR0210189A/pt not_active Application Discontinuation
- 2002-06-07 MX MXPA03011153A patent/MXPA03011153A/es unknown
- 2002-06-07 JP JP2003502200A patent/JP2004532046A/ja active Pending
- 2002-06-07 US US10/479,832 patent/US20050064407A1/en not_active Abandoned
- 2002-06-07 CA CA002449940A patent/CA2449940A1/en not_active Abandoned
- 2002-06-07 WO PCT/AU2002/000739 patent/WO2002099090A1/en not_active Application Discontinuation
- 2002-06-07 EP EP02729649A patent/EP1402007A1/en not_active Withdrawn
-
2003
- 2003-12-05 KR KR10-2003-7015959A patent/KR20040028771A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1402007A1 (en) | 2004-03-31 |
BR0210189A (pt) | 2004-08-03 |
US20050064407A1 (en) | 2005-03-24 |
CA2449940A1 (en) | 2002-12-12 |
JP2004532046A (ja) | 2004-10-21 |
WO2002099090A1 (en) | 2002-12-12 |
KR20040028771A (ko) | 2004-04-03 |
AUPR552701A0 (en) | 2001-07-12 |
IL159197A0 (en) | 2004-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69934227D1 (de) | Auf beta-arabinose, und dessen analogen, basierte antisense oligonukleotide | |
ATE484586T1 (de) | Synthetische doppelsträngige oligonucleotide zur gezielten hemmung der genexpression | |
ATE171210T1 (de) | Selbststabilisierte oligonukleotide als therapeutika | |
ATE283923T1 (de) | Gene für denitrifizierende enzyme | |
CA2177732A1 (en) | Antisense oligonucleotides having tumorigenicity-inhibiting activity | |
DK3222722T3 (da) | Antisense-design | |
PL328639A1 (en) | Synthesis of p5' phosphoamidane oligonucleotides n3' | |
MXPA03011153A (es) | Adn enzimas bcl-2. | |
WO2000014217A3 (en) | G-motif oligonucleotides and uses thereof | |
EP3040423A3 (en) | Microrna and uses thereof | |
EP1209228A3 (en) | Environmental stress responsive promoter | |
ATE293688T1 (de) | Chimerische antisense-oligonukleotide aus arabinofuranose-analogen und deoxyribose- nukleotide | |
Kaneko et al. | DNA methylation may restrict but does not determine differential gene expression at the Sgy/Tead2 locus during mouse development | |
ATE317436T1 (de) | Genveränderung im gen für die g$g(b)3- untereinheit des humanen g-proteins | |
US8283462B2 (en) | Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof | |
WO1999028439A3 (fr) | Erythrovirus et ses applications | |
ATE369422T1 (de) | Antisense-oligonukleotid zur hemmung der melanom- inhibierenden aktivität (mia) | |
MX2008013416A (es) | Medios para inhibir la expresion de cd31. | |
AU7425800A (en) | Single stranded oligonucleotides, probes, primers and method for detecting spirochetes | |
IT1320168B1 (it) | Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide. | |
Hosono et al. | Properties of base-pairing in the stem region of hairpin antisense oligonucleotides containing 2′-methoxynucleosides | |
CA2331333A1 (en) | Antisense oligonucleotide constructs based on .beta.-arabinofuranose and its analogues | |
WO2001051670A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
DK1537210T3 (da) | Decoy-oligonukleotid-inhibering af CD40-ekspression | |
HUP0400987A2 (hu) | Vírusellenes szerek |